Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Corporate Minority - II | Dead

Total Raised


Last Raised


About HiberGen

Researcher of genetic targets that can benefit present and future generations through the development of diagnostic and therapeutic products. The company is currently applying its genomic technologies to the genetically homogenous Irish population. The company's proprietary genotyping technology will identify SNPs of medical relevance with application in disease-gene identification and in personalized medicine (Pharmacogenomics). It is used in internal research projects and is available under license.

HiberGen Headquarter Location

IDA Business Park Southern Cross Road



353 1 2769870

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.